Association between asymmetric dimethylarginine and indices of vascular function in patients with essential hypertension. (Q51529434)

6 April 2018

title

Association between asymmetric dimethylarginine and indices of vascular function in patients with essential hypertension. (English)

1 reference

6 April 2018

9

Mihkel Zilmer

1 reference

6 April 2018

7

Kersti Zilmer

1 reference

6 April 2018

3

Jaak Kals

1 reference

6 April 2018

4

Maksim Zagura

1 reference

6 April 2018

1

Martin Serg

1 reference

6 April 2018

2

Priit Kampus

1 reference

6 April 2018

10

Jaan Eha

1 reference

6 April 2018

Piibe Muda

5

1 reference

6 April 2018

Tomi-Pekka Tuomainen

series ordinal

6

1 reference

6 April 2018

Erik Salum

series ordinal

8

1 reference

6 April 2018

publication date

8 December 2010

1 reference

6 April 2018

published in

Blood Pressure

1 reference

6 April 2018

volume

20

1 reference

6 April 2018

page(s)

111-116

1 reference

6 April 2018

issue

2

1 reference

6 April 2018

Images in cardiovascular medicine. Avoiding papillary muscle infarction with myocardial contrast echocardiographic guidance of nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy

cites work

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2010.533821

Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2010.533821

Asymmetric dimethylarginine, L-arginine, and endothelial dysfunction in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2010.533821

Pulse-wave analysis: clinical evaluation of a noninvasive, widely applicable method for assessing endothelial function

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2010.533821

2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2010.533821

Effects of stimulation of nitric oxide synthesis on large artery stiffness in patients with peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2010.533821

Reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2010.533821

Prognostic significance of endothelial dysfunction in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2010.533821

Does ADMA cause endothelial dysfunction?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2010.533821

Plasma asymmetric dimethylarginine and incidence of cardiovascular disease and death in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2010.533821

Plasma levels of asymmetrical dimethylarginine and adverse cardiovascular events after percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2010.533821

Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2010.533821

Nebivolol treatment reduces serum levels of asymmetric dimethylarginine and improves endothelial dysfunction in essential hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2010.533821

Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2010.533821

Endogenous nitric oxide synthase inhibitors, arterial hemodynamics, and subclinical vascular disease: the PREVENCION Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2010.533821

Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2010.533821

Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2010.533821

Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2010.533821

Relationship between carotid artery intima-media thickness and brachial artery flow-mediated dilation in middle-aged healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2010.533821

Mild-to-moderate hypertriglyceridemia in young men is associated with endothelial dysfunction and increased plasma concentrations of asymmetric dimethylarginine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2010.533821

ADMA and SDMA levels in healthy men exposed to tobacco smoke.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2010.533821

Asymmetric dimethylarginine, smoking, and risk of coronary heart disease in apparently healthy men: prospective analysis from the population-based Monitoring of Trends and Determinants in Cardiovascular Disease/Kooperative Gesundheitsforschung in de

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2010.533821

Relationship between obesity, smoking, and the endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08037051.2010.533821

10.3109/08037051.2010.533821

21 January 2018

Identifiers

DOI

1 reference

6 April 2018

PubMed ID

21142418

1 reference

6 April 2018